Home – About us – South Tees Research, Innovation and Education (STRIVE) – STRIVE Research – Academic Cardiovascular Unit (ACU) – Meet the ACU team – David Austin – David Austin’s publications

David Austin’s publications

This page contains a list of Dr David Austin's publications.

2025

Inhibition of fractalkine signalling reduces intramyocardial haemorrhage and left ventricular thrombus in patients with acute myocardial infarction by modulating immunothrombosis (The FRACTAL trial)

Early blood-derived predictors of final infarct size in patients with anterior STEMI and primary PCI

Cardiometabolic Outcomes with Dapagliflozin After Myocardial Infarction by Baseline Ejection Fraction: DAPA-MI

Discrepancies and potential impacts of self-reported versus measured height and weight on adult transthoracic echocardiography findings

Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study

The impact of drone delivery of an automated external defibrillator: a simulation feasibility study

2024

Automated external defibrillator location and socioeconomic deprivation in Great Britain

Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure

Role of Lipoprotein(a) Reduction in Cardiovascular Disease

Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial

Invasive Treatment Strategy for Older Patients with Myocardial Infarction

2023

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure

Fractalkine/CX3CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?

Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry

Automated external defibrillator location and socioeconomic deprivation in Great Britain

Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease

Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction

2022

Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT)

Impact of Sex on Clinical Outcomes in Patients undergoing Complex Percutaneous Coronary Angioplasty (from the e-ULTIMASTER Study)

Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry

Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction

Lipoprotein(a): Insights for the Practicing Clinician

Right ventricular mechanics in anthracycline chemotherapy: insights into the PROACT PLUS study

Atrial mechanics in anthracycline chemotherapy: insights into a prospective study

Anthracycline chemotherapy and its effects on left ventricular mechanics: insights into the PROACT PLUS study

2021

Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study

2020

The effects of doxorubicin on left and right atrial mechanics in patients with lymphoma

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial

Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality

Related pages